Remove Collective Remove Data Remove Media Remove Medicine
article thumbnail

The Effects of Big Data and Technology on the Marijuana Industry

SpeedWeed

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands.

Data 52
article thumbnail

Report: Gen Z Would Rather Smoke Cannabis Than Consume Alcohol

Veriheal

Understanding Gen Z Gen Z has been spotlighted in the media recently for a variety of reasons, one of which is that they are the largest consumers of media across any generation. California was the first state to legalize medicinal cannabis in 1996, right around the time that Gen Z began to enter society.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Finding ‘Releaf’: Put Data in Your Pipe and Smoke It

The Cannigma

When you walk into a hardware store, pharmacy, or even a liquor store, if you don’t know exactly what product will meet your needs there’s someone educated enough to point you to the right product and the data to back up that recommendation, says Tyler Dautrich, COO of Releaf.

Data 100
article thumbnail

Media Report Reveals German Govt Received Just Over 13 Million Euros Tax Revenue For Medicianl Cannabis In 2018

Cannabis Law Report

The full media report dated 30 August 2019 can be found at. million tax revenues through cannabis as medicine. According to a media report , the German government took almost 13.3 million euros in tax revenues with medicinal cannabis in 2018. These data are based on an extrapolation of the top pharmacist association.

Media 45
article thumbnail

Press Release: MindMed Engages in Pre-Submission Meeting with FDA for Development of the MindMed Session Monitoring System

Cannabis Law Report

9, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. MindMed is a clinical-stage psychedelic medicine biotech company that seeks to discover, develop and deploy psychedelic-inspired medicines and therapies to address addiction and mental illness. Thu, December 9, 2021, . NEW YORK , Dec. ” About MindMed.

article thumbnail

Cannabis consumers, real-world data, and why it matters

The Cannigma

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data 88
article thumbnail

Entheon Biomedical’s Wholly-Owned Subsidiary, HaluGen Life Sciences and Silo Wellness Announces Psychedelics Genetic Test Kit Partnership.

Cannabis Law Report

CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ( “Entheon” ), a biotechnology company focused on developing psychedelic medicines to treat addiction, and Silo Wellness Inc. For Entheon media inquiries, please contact Crystal Quast at: Bullseye Corporate. . – June 17, 2021) – Entheon Biomedical Corp. Crystal Quast.